www.i-canadianpharmacy.com
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Fenofibrate - Tricor, Actigall, Caduet, Lipitor, Neoral, Pravachol, Zocor
Generic Tricor
Generic Tricor is used for controlling high cholesterol and triglyceride levels in the blood. It is used in combination with a diet low in cholesterol and saturated fat. Generic Tricor is a lipid-lowering agent. It lowers elevated blood triglyceride levels by making the liver produce fewer triglycerides and increasing the elimination of triglycerides from the blood stream.
Generic Actigall
Ursodiol (ursodeoxycholic) 150/300mg
Generic Actigall is used for treating and preventing gallstones.
Generic Caduet
Generic Caduet is used for treating patients who have high cholesterol and high blood pressure or chest pain.
Generic Lipitor
Atorvastatin is used to lower cholesterol and triglyceride (fat-like substances) levels in the blood
Generic Neoral
Generic Neoral is used for preventing the rejection of organ transplants (kidney, liver, and heart). This medicine is also used to treat psoriasis and rheumatoid arthritis in certain patients.
Generic Pravachol
Reducing high lipid levels and high cholesterol, with diet and exercise.
Generic Zocor
Simvastatin is used to lower levels of cholesterol and other fats in the blood
- Testimonials
-
Great service ......very fast .......thanks !
Read more »
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- Treatment of chronic hemodialysis patients with low-dose fenofibrate ... - 7thSpace Interactive (press release)
- Treatment of chronic hemodialysis patients with low-dose fenofibrate
- Expect strong growth from US in FY13-14 - Moneycontrol.com
- Expect strong growth from US in FY13-14Moneycontrol
- Santarus' CEO Presents at Bank of America Merrill Lynch 2012 Health Care ... - Seeking Alpha
- Santarus' CEO Presents at Bank of America Merrill Lynch 2012 Health Care
- Santarus Reports First Quarter 2012 Financial Results - MarketWatch (press release)
- Santarus Reports First Quarter 2012 Financial ResultsMarketWatch (press release)FENOGLIDE(fenofibrate) tablets new prescriptions grew 17% and total prescriptions increased 11% for the four-week period ending April 20, 2012, compared with the four-week period ending February 3, 2012, which was just prior to Santarus' initiation of
- Santarus Announces Presentation of UCERIS Phase III Extended Use Data at ... - MarketWatch (press release)
- Santarus Announces Presentation of UCERIS Phase III Extended Use Data at
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
